Nippon India Pharma Fund vs SBI Healthcare Opportunities Fund compare
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹3689 Cr | ₹8352 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 31 Dec 2004 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 32% | 21% |
Expense Ratio | 1.94 | 1.82 |
Manager | Pradeep Kesavan | Sailesh Raj Bhan |
ISIN Code | INF200K01446 | INF204K01968 |
Exits Load | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | 2.35% | 2.68% |
6 Month | -0.84% | -0.42% |
1 Year | 20.64% | 16.99% |
3 Year | 28.76% | 25.58% |
5 Year | 23.8% | 22.05% |
SIP Return Analysis
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | 5.47% | 7.99% |
1 Year | 9.54% | 9.25% |
3 Year | 27.14% | 24.61% |
5 Year | 22.31% | 20.08% |
Rolling Lumpsum Returns
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 15.53% | 17.67% |
3 Year | 17.55% | 20.32% |
5 Year | 12.71% | 20.52% |
Risk Management
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | 13.97% | 14.96% |
Sharp | 1.32% | 1.07% |
Beta | 0.84% | 0.90% |
Alpha | 4.70% | 1.33% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Pradeep Kesavan | Sailesh Raj Bhan |
Total AUM | ₹434274 Cr | ₹96086 Cr |
Funds Managed | 43 | 5 |
SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 6.48 | 1.36 |
Small Cap | 37.63 | 27.14 |
Mid Cap | 28.02 | 32.78 |
Large Cap | 27.87 | 38.72 |
Sector Allocation
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 1.8 | 1.36 |
Basic Materials | 6.85 | - |
Healthcare | 91.34 | 98.64 |
Top Comparisons
SBI Retirement Benefit Fund - Aggressive Plan - Regular Plan - Growth
3Y Returns19.29%
Tata Retirement Savings Fund - Progressive Plan -Regular Plan-Growth Option
3Y Returns20.96%
Nippon India Balanced Advantage Fund-Growth Plan-Bonus Option
3Y Returns11.83%
Edelweiss Balanced Advantage Fund - Regular Plan - Growth Option
3Y Returns15.15%
INVESCO INDIA FOCUSED FUND - Growth
3Y Returns28.36%
UTI Focused Fund- Regular Plan - Growth Option
3Y Returns19.97%
ITI Value Fund Regular - Growth
3Y Returns24.25%
Bandhan Value Fund - Regular Plan - Growth
3Y Returns23.06%